Stroke risk and COVID-19
Stroke is comparatively frequent among patients with COVID-19 and has devastating consequences across all ages. The interaction of older age, comorbid conditions, and severity of COVID-19 metabolic process symptoms are related to very elevated mortality. Acute vessel disease, significantly anaemia stroke, has emerged as a heavy complication of infection by the severe acute respiratory syndrome coronavirus a pair of, the etiologic agent of the Coronavirus diseaseâ€2019.
- Therapy for communication disorders
- Psychological evaluation and treatment
Related Conference of Stroke risk and COVID-19
June 22-23, 2026
18th Global Neurologists Meeting on Neurology and Neurosurgery
Amsterdam, Netherlands
June 29-30, 2026
31st International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences
Paris, France
July 20-21, 2026
11th International Conference on Central Nervous System Disorders & Therapeutics
Amsterdam, Netherlands
July 23-24, 2026
14th International Conference on Cannabis & Medicinal Research
Amsterdam, Netherlands
September 17-18, 2026
31st Global Experts Meeting on Neuroscience and Neuropharmacology
Paris, France
April 27-28, 2027
18th International Conference on Stroke, Neurology and Cerebrovascular Diseases
Paris, France